Citation
Ogura, Jiro, et al. "Intestinal Ischemia-reperfusion Increases Efflux for Uric Acid Via Paracellular Route in the Intestine, but Decreases That Via Transcellular Route Mediated By BCRP." Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques, vol. 15, no. 2, 2012, pp. 295-304.
Ogura J, Kuwayama K, Takaya A, et al. Intestinal ischemia-reperfusion increases efflux for uric acid via paracellular route in the intestine, but decreases that via transcellular route mediated by BCRP. J Pharm Pharm Sci. 2012;15(2):295-304.
Ogura, J., Kuwayama, K., Takaya, A., Terada, Y., Tsujimoto, T., Koizumi, T., Maruyama, H., Fujikawa, A., Takahashi, N., Kobayashi, M., Itagaki, S., Hirano, T., Yamaguchi, H., & Iseki, K. (2012). Intestinal ischemia-reperfusion increases efflux for uric acid via paracellular route in the intestine, but decreases that via transcellular route mediated by BCRP. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques, 15(2), 295-304.
Ogura J, et al. Intestinal Ischemia-reperfusion Increases Efflux for Uric Acid Via Paracellular Route in the Intestine, but Decreases That Via Transcellular Route Mediated By BCRP. J Pharm Pharm Sci. 2012;15(2):295-304. PubMed PMID: 22579008.
TY - JOUR
T1 - Intestinal ischemia-reperfusion increases efflux for uric acid via paracellular route in the intestine, but decreases that via transcellular route mediated by BCRP.
AU - Ogura,Jiro,
AU - Kuwayama,Kaori,
AU - Takaya,Atsushi,
AU - Terada,Yusuke,
AU - Tsujimoto,Takashi,
AU - Koizumi,Takahiro,
AU - Maruyama,Hajime,
AU - Fujikawa,Asuka,
AU - Takahashi,Natsuko,
AU - Kobayashi,Masaki,
AU - Itagaki,Shirou,
AU - Hirano,Takeshi,
AU - Yamaguchi,Hiroaki,
AU - Iseki,Ken,
PY - 2012/5/15/entrez
PY - 2012/5/15/pubmed
PY - 2012/9/18/medline
SP - 295
EP - 304
JF - Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
JO - J Pharm Pharm Sci
VL - 15
IS - 2
N2 - PURPOSE: Uric acid is thought to be one of the most important antioxidants in human biological fluids. Intestinal ischemia-reperfusion (I/R) is an important factor associated with high rates of morbidity and mortality. Reactive oxygen species (ROS) are responsible for intestinal I/R injury. The aim of this study was to clarify the efflux for uric acid from the intestine after intestinal I/R. METHODS: We used intestinal ischemia-reperfusion (I/R) model rats. Serosal to mucosal flux for [¹⁴C]-uric acid was assessed by using Ussing-type diffusion chambers. BCRP/Bcrp expression was assessed by Western blot analysis. Caco-2 cells were used for a model of the intestinal epithelium, and rotenone was used as a mitochondrial dysfunction inducer. RESULTS: Serosal to mucosal flux for uric acid was increased after intestinal I/R, and that for mannitol was also increased. Ko143, which is a BCRP inhibitor, did not affect the uric acid transport. The decreasing uric acid transport mediated by Bcrp was caused by decrease in the level of Bcrp homodimer, bridged by an S-S bond. The suppression of Bcrp S-S bond formation was associated with mitochondrial dysfunction. Moreover, BCRP S-S bond formation activity was decreased by rotenone in Caco-2 cells. CONCLUSIONS: Serosal to mucosal flux for uric acid is significantly increased via the paracelluler route, but that via the transcellular route mediated by Bcrp is decreased after intestinal I/R. The decreasing uric acid flux mediated by Bcrp is caused by suppression of Bcrp S-S bond formation. This suppression of Bcrp S-S bond formation may be related to mitochondrial dysfunction.
SN - 1482-1826
UR - https://www.unboundmedicine.com/medline/citation/22579008/Intestinal_ischemia_reperfusion_increases_efflux_for_uric_acid_via_paracellular_route_in_the_intestine_but_decreases_that_via_transcellular_route_mediated_by_BCRP_
L2 - http://ejournals.library.ualberta.ca/index.php/JPPS/article/view/12242/13663
DB - PRIME
DP - Unbound Medicine
ER -